Further research is needed to determine the risks and benefits of particular sequences of biologic therapies in patients with rheumatoid arthritis who require treatment change owing to inefficacy ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

New developments in regenerative medicine are providing alternative solutions that aim to address the underlying issues of ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

The rheumatoid arthritis therapeutics market is ... globally and increased awareness about effective treatment options. Advances in biologic therapies have transformed management strategies ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

A study from Spain found a subcutaneous tocilizumab biosimilar to be cost-effective when treating patients with rheumatoid ...

The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...